Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Placebo

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGTHOE4512

    09/15/2015

    A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein


    Print this page for your doctor